Synapse - Sergio Giralt

Results (336)

Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies

Journal Article

Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
Blood Advances (2025)

Fulltext@MSK | Save

Genomic determinants of resistance to anti-BCMA chimeric antigen receptor T-cell (CART) therapies in patients with relapsed/refractory multiple myeloma

Meeting Abstract

Maura, F.; Freeman, C. L.; Lee, H.; Maclachlan, K. H.; Durante, M.; Ziccheddu, B.; Menges, M.; Diamond, B.; Papadimitriou, M.; Silva, A. S.; more...
Blood (2024)

Fulltext@MSK | Save

Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease

Meeting Abstract

Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
Blood (2024)

Fulltext@MSK | Save

Treatment patterns of immunoglobulin replacement therapy among patients with multiple myeloma in the United States: A real-world analysis

Meeting Abstract

Ida, F.; Ramakrishna, B.; Nasserinejad, K.; Radu, A.; Lawo, J. P.; Zhang, X.; Gardiner, D.; Yoon, L.; Shen, J.; Dabrowski, E. C.; more...
Blood (2024)

Fulltext@MSK | Save

Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma

Meeting Abstract

Costa, B. A.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
Blood (2024)

Fulltext@MSK | Save

Defining the rates of cytokine release syndrome associated with talquetamab step-up doses

Meeting Abstract

Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
Blood (2024)

Fulltext@MSK | Save

Comparison of acute kidney injury in patients with relapsed or refractory multiple myeloma following CAR T-cell and bispecific antibody therapies

Meeting Abstract

Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Farzana, T.; Shaikh, A.; Latcha, S.; Gutgarts, V.; Jurgens, E. M.; more...
Blood (2024)

Fulltext@MSK | Save

Body mass index trajectory during triplet induction therapy: Clinical implications in newly diagnosed multiple myeloma

Meeting Abstract

Thirugnanasambandam, R. P.; Firestone, R. S.; Derkach, A.; Furberg, H.; Shekarkhand, T.; Rueda, C.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; Patel, D.; more...
Blood (2024)

Fulltext@MSK | Save

Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma

Meeting Abstract

Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
Blood (2024)

Fulltext@MSK | Save

Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
Blood (2024)

Fulltext@MSK | Save

Sergio Andres Giralt

Results (336)

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract